Scientific Exchange: Concepts and Practices in the Field of Electrophysiology
-
15m 37sPart 1 | Session 2 Hemolysis Pathophysiology and Clinical Implications
-
14m 22sPart 1 | Session 3 Hemolysis Incidence Across PFA Technologies
-
14m 57sPart 1 | Session 4 Real-World Experience With PFA and Patient Selection
-
13m 1sPart 1 | Session 5 Panel Discussion and Q&A
-
3m 8sPart 2 | Session 1 Welcome
-
19m 38sPart 2 | Session 2 Lesion Durability and Workflow
-
21m 53sPart 2 | Session 3 Standardized Workflow in a Multi-Operator Center
-
18m 14sPart 2 | Session 4 Panel Discussion and Q&A
-
8m 2sPart 3 | Session 1 Introduction and Insights From Our Experience With PulseSelect
-
15m 1s
-
9m 26sPart 3 | Session 3 Not All PFA Is Created Equal: Discussion
-
17m 17sPart 3 | Session 4 Implementing PulseSelect Into Daily Practice: Learnings and Early Results
-
11m 12sPart 3 | Session 5 Implementing PulseSelect Into Daily Practice: Discussion
Nishaki Mehta introduces the session, outlines the program and provides the educational goals.
The Scientific Exchange webinar series features presentations and peer-to-peer discussions with experts on advanced concepts and practices in electrophysiology.
Learning Objectives
- Hemolysis overview: pathophysiology, detection and clinical consequences from a hematologist perspective
- Review recently presented data on durability with PulseSelect PFA Ablation Catheter
- Learn about the latest innovations in pulsed field ablation
Target Audience
- Electrophysiologists
- Cardiologists
- Fellows
- Allied Healthcare Professionals
More from this programme
Part 1
Hemolysis With Different PFA Technologies: Clinical Considerations
This one-hour session provides a concise and practical overview of hemolysis including its pathophysiology, detection and clinical consequences. Gain actionable insights into hemolysis and PFA technologies through a review of preclinical data as well as real-world strategies for patient selection and procedural optimization.
Part 2
Durability Study With PulseSelect Pulsed Field Ablation (PFA) System and Real-World Experience
This program features presentations and interactive discussion focused on the recently presented data on PulseSelect PFA system and new clinical research on durability with PFA. Faculty also discuss efficiency workflow tips and a multi-user center’s real-world experience.
Part 3
PulseSelect PFA: Rapid Adoption in Everyday Practice With a Dedicated EP Catheter
Learn about the unique value of the PulseSelect PFA system as a dedicated EP technology specifically designed for Pulsed Field Ablation (PFA). Hear from expert users how the PulseSelect technology facilitates easy adoption of PFA into various EP workflows, enabling its daily use with minimal learning curves and consistent performance. See cases-in-the-box featuring practical tips for safe, effective and efficient PFA procedures.
Faculty Biographies
Nishaki Mehta
Cardiac Electrophysiologist
Dr Nishaki Mehta is a Cardiac Electrophysiologist at Corewell William Beaumont University Hospital, Michigan, US.
Dr Mehta specialises in electrophysiology, focusing on treating abnormal heart rhythms with devices such as pacemakers and defibrillators. Her expertise includes complex ablations as well as the implantation of complex devices.
Jay Raval
Clinical Pathologist
Dr Jay Raval is a Clinical Pathologist and Professor in the Department of Pathology and Laboratory Medicine at University of Vermont Medical Center, Vermont, US. He directs and guides operations for clinical pathology and supports the therapeutic apheresis programme.
Dr Raval's specialties include clinical pathology and blood banking / transfusion medicine.
He received his medical degree from the University of North Carolina at Chapel Hill where he was a Howard Holderness Distinguished Medical Student Research Scholar.
Atul Verma
Director of Cardiology
Dr Atul Verma is currently Director of Cardiology at the McGill University Health Centre & McGill University, Montreal, CA.
Specialising in complex arrhythmias like atrial fibrillation and ventricular tachycardia, he has published over 300 peer-reviewed articles including in The New England Journal of Medicine. Dr Verma has co-chaired the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee and contributed to the HRS/EHRA Consensus Document on Catheter Ablation of Atrial Fibrillation. He currently leads and participates in multiple international clinical trials.
Stavros Mountantonakis
Cardiac Electrophysiologist
Dr Stavros Mountantonakis is a Cardiac Electrophysiologist at Lenox Hill Hospital, New York, US.
Dr Mountantonakis has carried out extensive research on both invasive and noninvasive treatments for atrial fibrillation and ventricular tachycardia. His work focuses on applying innovative technologies for diagnosing and treating these conditions and he has authored numerous articles in high-impact journals.